Medtronic is to launch the OsteoCool radiofrequency ablation system for surgeons who treat patients with painful spinal metastases. The system has been granted US Food and Drug Administration (FDA) 510(k) marketing clearance.
The first US implant of the Gore Excluder thoracoabdominal branch endoprosthesis has taken place during a clinical study of the treatment of aortic aneurysms involving the visceral branch vessels.
The IN.PACT Admiral drug-eluting balloon (DEB) has been granted CE mark for arteriovenous (AV) access to help maintain haemodialysis access in patients with end-stage renal disease, according to a Medtronic press release.
Vivasure Medical has been granted CE mark approval for its fully bioabsorbable percutaneous vascular closure device for large-bore femoral arteriotomies. According to Vivasure, this is the world’s first approved bioabsorbable, sutureless and fully synthetic option to close large arteriotomies, which result from percutaneous transcatheter procedures.
Early research on a simple method to produce radiopaque drug-eluting microspheres that can be incorporated into the current clinical transcatheter arterial chemoembolization workflow has also been reported.
Forge Medical has announced receiving 510(k) clearance from the US FDA for expanded indications of the device to include pedal and tibial haemostasis. The VasoStat was previously cleared for radial artery and dialysis access haemostasis.
Penumbra’s POD (Penumbra Occlusion Device) packing coil for the embolization of peripheral vessels and aneurysms adds to its growing peripheral vascular business, which includes the Indigo mechanical thrombectomy system, POD and Ruby embolization coil.
NuCryo Vascular has announced receiving 510(k) clearance on the next generation reusable Cryoplasty inflation device. The company has also announced that it will be selling the current and next generation model via a direct sales team.
The MobiusHD minimally invasive system from Vascular Dynamics has been granted CE mark approval for the treatment of resistant hypertension.
Argon Medical Devices has completed the acquisition of three vascular products from Rex Medical. The OptionELITE retrievable vena cava filter, Cleaner rotational thrombectomy system, and UltraStream chronic haemodialysis catheter are now wholly owned by Argon Medical Devices.
As of mid-December 2015, researchers have activated the first 10 medical sites and enrolled the first nine patients in a large US study that will determine the safety and effectiveness of inferior vena cava filters.
Patients who feel scared, distressed or hostile before undergoing an interventional radiology procedure may experience a poor outcome, according to research presented at the Radiological Society of North American Annual Meeting (RSNA) in Chicago in early December.
Medtronic will manufacture the IN.PACT Admiral drug-coated balloon (DCB) for the treatment of peripheral artery disease (PAD) at a new facility in Galway, Ireland.
BTG has announced the successful outcome of the RENEW study, the pivotal US randomised controlled clinical trial comparing the safety and efficacy of the PneumRx endobronchial coil implant with a medical therapy control group in patients with homogeneous and/or heterogeneous severe emphysema. All primary and secondary endpoints of the study were met.
ArtVentive Medical has conducted the first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS Gen II). The EOS is designed for use in the peripheral vasculature and offers immediate and permanent vessel occlusion in arterial and venous settings.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos